Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC

NCT06793553 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Induction therapy

Sponsor

Japan Breast Cancer Research Group

Collaborators

[object Object]